JP2020500909A5 - - Google Patents

Download PDF

Info

Publication number
JP2020500909A5
JP2020500909A5 JP2019530790A JP2019530790A JP2020500909A5 JP 2020500909 A5 JP2020500909 A5 JP 2020500909A5 JP 2019530790 A JP2019530790 A JP 2019530790A JP 2019530790 A JP2019530790 A JP 2019530790A JP 2020500909 A5 JP2020500909 A5 JP 2020500909A5
Authority
JP
Japan
Prior art keywords
alkyl
heteroaryl
heterocyclyl
alkynyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019530790A
Other languages
English (en)
Japanese (ja)
Other versions
JP7064495B2 (ja
JP2020500909A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2017/114970 external-priority patent/WO2018103688A1/en
Publication of JP2020500909A publication Critical patent/JP2020500909A/ja
Publication of JP2020500909A5 publication Critical patent/JP2020500909A5/ja
Priority to JP2022070763A priority Critical patent/JP2022090051A/ja
Application granted granted Critical
Publication of JP7064495B2 publication Critical patent/JP7064495B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019530790A 2016-12-07 2017-12-07 PI3Kδ阻害剤としてのイミダゾ[1,5-a]ピラジン誘導体 Expired - Fee Related JP7064495B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022070763A JP2022090051A (ja) 2016-12-07 2022-04-22 PI3Kδ阻害剤としてのイミダゾ[1,5-a]ピラジン誘導体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2016108897 2016-12-07
CNPCT/CN2016/108897 2016-12-07
PCT/CN2017/114970 WO2018103688A1 (en) 2016-12-07 2017-12-07 IMIDAZO [1,5-A] PYRAZINE DERIVATIVES AS PI3Kdelta INHIBITORS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022070763A Division JP2022090051A (ja) 2016-12-07 2022-04-22 PI3Kδ阻害剤としてのイミダゾ[1,5-a]ピラジン誘導体

Publications (3)

Publication Number Publication Date
JP2020500909A JP2020500909A (ja) 2020-01-16
JP2020500909A5 true JP2020500909A5 (https=) 2021-01-21
JP7064495B2 JP7064495B2 (ja) 2022-05-10

Family

ID=62491736

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019530790A Expired - Fee Related JP7064495B2 (ja) 2016-12-07 2017-12-07 PI3Kδ阻害剤としてのイミダゾ[1,5-a]ピラジン誘導体
JP2022070763A Pending JP2022090051A (ja) 2016-12-07 2022-04-22 PI3Kδ阻害剤としてのイミダゾ[1,5-a]ピラジン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022070763A Pending JP2022090051A (ja) 2016-12-07 2022-04-22 PI3Kδ阻害剤としてのイミダゾ[1,5-a]ピラジン誘導体

Country Status (16)

Country Link
US (2) US11136323B2 (https=)
EP (1) EP3551630A4 (https=)
JP (2) JP7064495B2 (https=)
KR (1) KR20190091339A (https=)
CN (2) CN110267959B (https=)
AU (2) AU2017372377B2 (https=)
BR (1) BR112019011847A2 (https=)
CA (1) CA3045959A1 (https=)
EA (1) EA201991355A1 (https=)
IL (2) IL266986B (https=)
MX (1) MX394882B (https=)
NZ (1) NZ754944A (https=)
SG (1) SG10201912192RA (https=)
TW (2) TW202233190A (https=)
WO (1) WO2018103688A1 (https=)
ZA (1) ZA201903286B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3045959A1 (en) 2016-12-07 2018-06-14 Beigene, Ltd. Imidazo [1,5-a] pyrazine derivatives as pi3kdelta inhibitors
BR112020004500A2 (pt) * 2017-09-08 2020-12-01 Beigene, Ltd. derivados de imidazo [1,5-a] pirazina como inibidores de pi3kdelta
US20230011916A1 (en) * 2019-11-21 2023-01-12 Beigene, Ltd. Methods of cancer treatment using anti-ox40 antibodies in combination with pi3 kinase delta inhibitors
KR102344185B1 (ko) * 2020-02-26 2021-12-27 계명대학교 산학협력단 신규한 Pim 키나아제 억제제 및 이의 용도
AU2022280905A1 (en) * 2021-05-27 2024-01-18 Beigene Switzerland Gmbh SALTS OF A PI3Kdelta INHIBITOR, CRYSTALLINE FORMS, METHODS OF PREPARATION, AND USES THEREFORE
WO2023040810A1 (en) * 2021-09-14 2023-03-23 Beigene, Ltd. Methods of cancer treatment using a combination of btk inhibitors and pi3 kinase inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83509C2 (en) 2003-10-15 2008-07-25 Оси Фармасьютикалз, Инк. Imidazopyrazines as tyrosine kinase inhibitors
BRPI1014572B8 (pt) 2009-04-16 2022-07-19 Fundacion Centro Nac De Investigaciones Oncologicas Carlos Iii Imidazopirazinas para uso como inibidores de cinase
RU2013138835A (ru) 2011-02-09 2015-03-20 Ф. Хоффманн-Ля Рош Аг Гетероциклические соединения в качестве ингибиторов pi3 киназы
ES2588186T3 (es) * 2012-01-10 2016-10-31 Bayer Intellectual Property Gmbh Imidazopirazinas sustituidas como inhibidores de la quinasa Akt
AU2013337717B2 (en) 2012-11-01 2018-10-25 Infinity Pharmaceuticals, Inc. Treatment of cancers using PI3 kinase isoform modulators
CA2914284A1 (en) 2013-05-30 2014-12-04 Infinity Pharmaceuticals, Inc. Treatment of cancers using pi3 kinase isoform modulators
CA2922058A1 (en) * 2013-10-18 2015-04-23 Medivation Technologies, Inc. Heterocyclic compounds and methods of use
PL3179991T3 (pl) 2014-08-11 2022-02-14 Acerta Pharma B.V. Kombinacje terapeutyczne inhibitora btk i inhibitora bcl-2
CA3045959A1 (en) * 2016-12-07 2018-06-14 Beigene, Ltd. Imidazo [1,5-a] pyrazine derivatives as pi3kdelta inhibitors
BR112020004500A2 (pt) 2017-09-08 2020-12-01 Beigene, Ltd. derivados de imidazo [1,5-a] pirazina como inibidores de pi3kdelta

Similar Documents

Publication Publication Date Title
JP2020500909A5 (https=)
JP2020534259A5 (https=)
JP2014514317A5 (https=)
MX2021009763A (es) Derivados de 3-(1-oxo-5-(piperidin-4-il)isoindolin-2-il)piperidina -2,6-diona y usos de los mismos.
WO2015132799A3 (en) Heterocyclic compounds
ES2855732T3 (es) Compuestos y composiciones para tratar afecciones asociadas con la actividad de NLRP
JP2015531773A5 (https=)
JP2017509586A5 (https=)
JP2018511587A5 (https=)
CN110582489A (zh) Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途
JP2016503779A5 (https=)
JP2016523269A5 (https=)
JP2019532930A5 (https=)
JP2012140432A5 (https=)
JP2009511490A5 (https=)
HRP20171453T1 (hr) Derivati imidazotiadiazola i imidazopirazina kao inhibitori proteazom aktiviranog receptora 4 (par4) za liječenje agregacije trombocita
JP2018529739A5 (https=)
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
JP2017500338A5 (https=)
JP2016513660A5 (https=)
JP2016525075A5 (https=)
HRP20211392T1 (hr) INHIBITOR EGFR -a, I NJEGOVA PRIPREMA I PRIMJENA
JP2014518544A5 (https=)
JP2018525375A5 (https=)
JP2016507581A5 (https=)